⌘K

Login Start Free

Home/Filings/4/0001839882-23-004701

4//SEC Filing

LEDERMAN SETH 4

Accession 0001839882-23-004701

CIK 0001430306other

View on SEC.gov Company Profile

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 6:34 PM ET

Size

7.9 KB

Accession

0001839882-23-004701

Insider Transaction Report

Form 4

Period: 2023-02-23

Tonix Pharmaceuticals Holding Corp.TNXP

DirectorPresident and CEO

Transactions

Award
Stock Option
2023-02-23+700,000→ 700,000 total
Exercise: $0.91From: 2024-02-23Exp: 2033-02-23→ Common Stock (700,000 underlying)
Award
Stock Option
2023-02-23+700,000→ 700,000 total
Exercise: $0.73From: 2024-02-23Exp: 2033-02-23→ Common Stock (700,000 underlying)

Footnotes (2)

[F1]One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
[F2]The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.

Documents

1 file

4
lederman-form4_022322.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Issuer

Tonix Pharmaceuticals Holding Corp.

CIK 0001430306

Entity typeother

Related Parties

1

filerCIK 0001563420

Filing Metadata

Form type: 4
Filed: Feb 23, 7:00 PM ET
Accepted: Feb 24, 6:34 PM ET
Size: 7.9 KB

View on SEC.gov